Sentry Investment Management LLC Sells 47 Shares of HCA Healthcare, Inc. $HCA

Sentry Investment Management LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 527 shares of the company’s stock after selling 47 shares during the period. Sentry Investment Management LLC’s holdings in HCA Healthcare were worth $199,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Cheviot Value Management LLC bought a new position in HCA Healthcare during the first quarter worth about $26,000. Saudi Central Bank bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $27,000. Ameriflex Group Inc. bought a new position in shares of HCA Healthcare in the second quarter valued at approximately $27,000. Finally, Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare in the second quarter valued at approximately $27,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Up 1.4%

Shares of HCA stock opened at $425.50 on Monday. The firm has a market capitalization of $99.56 billion, a price-to-earnings ratio of 17.89, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $439.01. The firm has a fifty day moving average of $410.05 and a 200-day moving average of $378.63.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the prior year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were paid a $0.72 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 12.11%.

Wall Street Analyst Weigh In

HCA has been the subject of several research analyst reports. Cantor Fitzgerald restated an “overweight” rating and issued a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 7th. KeyCorp lifted their target price on shares of HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Morgan Stanley lowered their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a report on Monday, July 28th. UBS Group lifted their target price on shares of HCA Healthcare from $438.00 to $495.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Finally, Mizuho boosted their price target on shares of HCA Healthcare from $425.00 to $475.00 and gave the company an “outperform” rating in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $437.19.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.